News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GILL JOHN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 07/06/2023 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 2,714 shares
@ $15, valued at
$40.7k
|
|
| 09/30/2022 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 23,500 options to buy
@ $12.62, valued at
$296.6k
|
|
| 02/14/2022 |
5
| GILL JOHN (Director) has filed a Form 5 on Altimmune, Inc. |
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 8,425 shares
@ $11.92, valued at
$100.4k
|
|
| 10/16/2020 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Exercised 16,850 options to buy
@ $0 |
|
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.6, valued at
$52k
|
|
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2016 |
4
| GILL JOHN (President and CEO) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Exercised 20,000 options to buy
@ $1.6, valued at
$32k
Exercised 20,000 options to buy
@ $1.45, valued at
$29k
Exercised 20,000 options to buy
@ $1.64, valued at
$32.8k
Exercised 20,000 options to buy
@ $1.51, valued at
$30.2k
Exercised 10,000 options to buy
@ $2.59, valued at
$25.9k
Exercised 20,000 options to buy
@ $2.47, valued at
$49.4k
|
|
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2012 |
4
| GILL JOHN (Director) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Granted 20,000 options to buy
@ $1.45, valued at
$29k
|
|
| 06/27/2011 |
4
| GILL JOHN (Director) has filed a Form 4 on PHARMATHENE, INC|
Txns:
| Granted 20,000 options to buy
@ $3.11, valued at
$62.2k
|
|
| 06/25/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/18/2009 |
4
| GILL JOHN (Director) has filed a Form 4 on PHARMATHENE, INC |
| 08/07/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 03/11/2009 |
4
| GILL JOHN (Director) has filed a Form 4 on PHARMATHENE, INC |
|
|